[Close]Chrome and Firefox do not support the opening and saving of this type of PDF, and the "Please wait…" message you get when clicking on it is an error message in disguise.

To download from the "Please wait" page, move your cursor to the top right, click on the download icon, and choose where to save it on your computer. Once saved, you will be able to open with Adobe Acrobat reader and use all of the features of the action plan. Email info@GetAsthmaHelp.org for more help.

Asthma News – October 14, 2021

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails.

Check out the most recent MDHHS asthma social media messages and share them with your networks.

Register Now! Asthma Educator Sharing Times - Oct. 22 & 29, 11 am to 2 pm

Asthma Educator Sharing Day 2021 is being split into TWO virtual Asthma Educator Sharing Times, to learn about current interventions and treatments for the management of asthma, and techniques to improve asthma education in all settings. Applications for 3 RN and RT contact hours/event pending. Registration for Oct. 29 event still open!

Severe COVID-19 among patients with asthma and chronic obstructive pulmonary disease (COPD)

A report from the Swedish National Airway Register found that The frequency of severe COVID-19 in asthma and COPD was relative low. Mortality for those hospitalized was double as high in COPD compared to asthma. Comorbid asthma and COPD were not always identified among patients with severe COVID-19.

Inhaled Corticosteroids (ICS) Increase Risk of Nontuberculous Mycobacterial Lung Disease (NTM-LD)

NTM-LD was associated with use, dose, and duration of exposure to ICS; however, discontinuation of ICS for 120 days or more may significantly decrease the risk for NTM-LD, according to new study results. Low-, moderate-, and high-dose ICS were all found to be associated with the increased risk.

Childhood asthma study uncovers risky air pollutant mixtures

A new study examined early exposure to dozens of pollutants potentially experienced by children with mild to severe forms of the disease. While some cases could be linked to an individual, established air pollutant, others appeared to be linked to mixtures of pollutants that had never been associated with asthma.

Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies

Inhaled corticosteroid (ICS)/long-acting β2-adrenoceptor agonist/long-acting muscarinic receptor antagonist fixed-dose combination therapies appeared to be safe and effective for the treatment of uncontrolled asthma. The dose of ICS used in the combination therapies represents the discriminating factor for treating patients with a history of moderate or severe asthma exacerbations.

November MDHHS Asthma Social Media Messages Now Available

Asthma-related social media messages are now available, please share them within your personal or organizational networks!

Electronic cigarette (e-cigarette) use and frequency of asthma symptoms in adult asthmatics in California

Findings of a new study suggest that e-cigarette use is associated with more frequent asthma symptoms and disproportionally affects male asthmatics.

Tezepelumab for Severe Asthma - Institute for Clinical and Economic Review Draft Evidence Report (pdf)

The report found that tezepelumab reduces exacerbations among patients who have severe asthma, including some types of asthma that lack other effective biologic therapies. It also yielded relatively small improvements in daily symptoms and quality of life, and models suggested it would exceed typical cost-effectiveness thresholds.